Abraar Karan

An MD candidate at the University of California, Los Angeles, David Geffen School of Medicine, US.

Content by Abraar Karan:

 Outside the Lab Public health

#Ebola

| Abraar Karan

The Ebola epidemic spurred a tremendous amount of R&D in search of vaccines and treatments – and yet it was a relatively low impact global emergency compared with malaria.
Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register

October Issue of The Translational Scientist